PYRIDYLPIPERIDINE

European patent · EP3122739 · Deleted

Register entry

Publication number
EP3122739
Application number
EP15709097
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 10, 2015
Published
Feb 1, 2017
Granted
Jan 16, 2019
Deleted
Oct 25, 2023
Reason
Annual fee unpaid
IPC classes
C07D 401/14 (2006.01)
C07D 471/10 (2006.01)
C07D 471/20 (2006.01)
A61K 31/444 (2006.01)
A61P 35/00 (2006.01)
A61P 19/02 (2006.01)
A61P 25/16 (2006.01)
Priority
EP 14001145 27.03.2014
PCT application
PCT/EP2015/000528 10.03.2015
PCT publication
WO2015/144290 01.10.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 25, 2023

    Deleted, fee unpaid

    Published in Swissreg on 25.10.2023

  2. Jan 16, 2019

    Granted

    Published in Swissreg on 16.01.2019

Parties

Holder

CANCER RESEARCH TECHNOLOGY LIMITED

Cancer Research Technology Limited

Angel Building 407 St. John Street, London EC1V 4AD, GB

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Inventor

RINK, Christian

53125 Bonn, DE

CRUMPLER, Simon Ross

Essex CB11 3XY, GB

SCHIEMANN, Kai

64342 Seeheim-Jugenheim, DE

STIEBER, Frank

64683 Einhausen, DE

CALDERINI, Michel

64291 Darmstadt, DE

BLAGG, Julian

Carshalton Beeches Surrey SM5 4EA, GB

MALLINGER, Aurelie

F-54800 Affleville, FR

WAALBOER, Dennis

NL-1974 PH Ljmuiden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.